These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12433807)

  • 1. Kinetic study of the reaction of cisplatin with thiols.
    Dabrowiak JC; Goodisman J; Souid AK
    Drug Metab Dispos; 2002 Dec; 30(12):1378-84. PubMed ID: 12433807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic study on the reactions of platinum drugs with glutathione.
    Hagrman D; Goodisman J; Souid AK
    J Pharmacol Exp Ther; 2004 Feb; 308(2):658-66. PubMed ID: 14610218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic study on the reaction of cisplatin with metallothionein.
    Hagrman D; Goodisman J; Dabrowiak JC; Souid AK
    Drug Metab Dispos; 2003 Jul; 31(7):916-23. PubMed ID: 12814969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs.
    Sadowitz PD; Hubbard BA; Dabrowiak JC; Goodisman J; Tacka KA; Aktas MK; Cunningham MJ; Dubowy RL; Souid AK
    Drug Metab Dispos; 2002 Feb; 30(2):183-90. PubMed ID: 11792689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of the reactions of 4-hydroperoxycyclophosphamide and acrolein with glutathione, mesna, and WR-1065.
    Tacka KA; Dabrowiak JC; Goodisman J; Souid AK
    Drug Metab Dispos; 2002 Aug; 30(8):875-82. PubMed ID: 12124304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding kinetics of tetrachloro-1,2-diaminocyclohexaneplatinum (IV) (tetraplatin) and cis-diamminedichloroplatinum (II) at 37 degrees C with human plasma proteins and with bovine serum albumin. Does aquation precede protein binding?
    LeRoy AF; Thompson WC
    J Natl Cancer Inst; 1989 Mar; 81(6):427-36. PubMed ID: 2918550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired hydrolysis of cisplatin derivatives to aquated species prevents energy-dependent uptake in GLC4 cells resistant to cisplatin.
    Pereira-Maia E; Garnier-Suillerot A
    J Biol Inorg Chem; 2003 Jul; 8(6):626-34. PubMed ID: 12756611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemical reactivity of the modulating agent WR2721 (ethiofos) and its main metabolites with the antitumor agents cisplatin and carboplatin.
    Treskes M; Holwerda U; Klein I; Pinedo HM; van der Vijgh WJ
    Biochem Pharmacol; 1991 Nov; 42(11):2125-30. PubMed ID: 1659819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reaction kinetics of cisplatin and its monoaquated species with the (potential) renal protecting agents (di)mesna and thiosulfate. Estimation of the effect of protecting agents on the plasma and peritoneal AUCs of CDDP.
    Leeuwenkamp OR; van der Vijgh WJ; Neijt JP; Pinedo HM
    Cancer Chemother Pharmacol; 1990; 27(2):111-4. PubMed ID: 2174306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive reactions among glutathione, cisplatin and copper-phenanthroline complexes.
    Cadoni E; Valletta E; Caddeo G; Isaia F; Cabiddu MG; Vascellari S; Pivetta T
    J Inorg Biochem; 2017 Aug; 173():126-133. PubMed ID: 28511063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).
    Ohmori T; Morikage T; Sugimoto Y; Fujiwara Y; Kasahara K; Nishio K; Ohta S; Sasaki Y; Takahashi T; Saijo N
    Jpn J Cancer Res; 1993 Jan; 84(1):83-92. PubMed ID: 8383649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPLC determination of binding of cisplatin to DNA in the presence of biological thiols: implications of dominant platinum-thiol binding to its anticancer action.
    Volckova E; Dudones LP; Bose RN
    Pharm Res; 2002 Feb; 19(2):124-31. PubMed ID: 11883638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
    Teicher BA; Holden SA; Kelley MJ; Shea TC; Cucchi CA; Rosowsky A; Henner WD; Frei E
    Cancer Res; 1987 Jan; 47(2):388-93. PubMed ID: 3539321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental and theoretical studies on the pharmacodynamics of cisplatin in jurkat cells.
    Tacka KA; Szalda D; Souid AK; Goodisman J; Dabrowiak JC
    Chem Res Toxicol; 2004 Nov; 17(11):1434-44. PubMed ID: 15540941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG.
    Verschraagen M; Kedde MA; Hausheer FH; Van Der Vijgh WJ
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):499-504. PubMed ID: 12715205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
    Meijer C; Mulder NH; Hospers GA; Uges DR; de Vries EG
    Br J Cancer; 1990 Jul; 62(1):72-7. PubMed ID: 2390486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy.
    Pendyala L; Schwartz G; Smith P; Zdanowicz J; Murphy M; Hausheer F
    Cancer Chemother Pharmacol; 2003 May; 51(5):376-84. PubMed ID: 12682786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPLC determination of cis-diamminedichloroplatinum(II) in plasma and urine with UV detection and column-switching.
    Kizu R; Hayakawa K; Miyazaki M
    Biomed Chromatogr; 1989 Jan; 3(1):14-9. PubMed ID: 2706360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of protein thiols in inhibition of sodium-coupled glucose uptake by cisplatin in renal brush-border membrane vesicles.
    Potdevin S; Courjault-Gautier F; Du Sorbier BM; Ripoche P; Toutain HJ
    J Pharmacol Exp Ther; 1998 Jan; 284(1):142-50. PubMed ID: 9435172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T; Masuda H; Naito M; Tamai H
    Anticancer Res; 2001; 21(4A):2463-9. PubMed ID: 11724308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.